相关实验视频
Updated: May 29, 2025

09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
15.4K
Lp (a) 度和多态尺寸与糖尿病前期患者的新发糖尿病无关
Maxime Carpentier1, Matthieu Wargny2, Mikaël Croyal3
1Nantes Université, CNRS, CHU Nantes, INSERM, l'institut du thorax, F-44000, Nantes, France; Department of Biochemistry, CHU Nantes, F-44000, Nantes, France.
Diabetes & metabolism
|February 5, 2025
概括
脂蛋白 (a) [Lp(a]水平和克林格尔-IV (K-IV) 重复变化与糖尿病前期患者的新发型2型糖尿病没有联系. 这项研究没有发现Lp(a) 或K-IV与这种高风险组的糖尿病风险之间存在显著的关联.
科学领域:
- 心血管研究研究心血管研究
- 代谢性疾病研究研究
- 糖尿病 流行病学 流行病学
背景情况:
- 以前的研究表明,低脂蛋白 (a) [Lp(a) ]度与一般人群中2型糖尿病风险增加之间存在联系.
- 血Lp (a) 度和Kringle-IV (K-IV) 重复多态性在糖尿病前期进展到糖尿病中的作用仍然不清楚.
研究的目的:
- 研究Lp(a) 血度和K-IV重复多态与糖尿病前期患者新发型糖尿病 (NOD) 之间的关联.
- 为了确定Lp(a) 水平或K-IV多态性是否预测高风险队列中的2型糖尿病发展.
主要方法:
- 在IT-DIAB研究中,有303名糖尿病前期参与者 (禁食血葡萄糖[FPG]:110-125毫克/分升) 被前性跟踪了5年.
- 新发型糖尿病被定义为FPG≥126 mg/dl. 测量了Lp (a) 和K-IV域.
- 生存分析使用卡普兰-梅尔曲线和多变量考克斯模型.
主要成果:
- 在303名参与者中,113名 (37%) 患有NOD. 在那些有和没有发展NOD的人之间,没有观察到Lp (a) 度或K-IV域的显著差异.
- 分析显示,Lp (a) 度值 (7nmol/l,125nmol/l) 或K-IV域数 (值23) 与NOD风险之间没有关联.
结论:
- 在糖尿病前期患者中,Lp (a) 度和K-IV多态大小与患2型糖尿病的风险没有实质性关联.
- 这些发现表明,Lp (a) 可能不是高风险糖尿病前期人群2型糖尿病发病的重要预测因素.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
852
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
852
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Dipeptidyl Peptidase 4 Inhibitors
164
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
164
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K

